Ortin Laboratories Ltd

Ortin Global Limited announced the outcome of its Board Meeting held on August 14, 2026. The board considered and approved the unaudited financial results for the quarter ended June 30, 2026, along with the Limited Review Report. The company's operations are in a single segment, making segmental reporting inapplicable. The financial results were prepared in accordance with Indian Accounting Standards (Ind AS).

Ortin Global Limited announced its unaudited financial results for the quarter ended June 30, 2026. The Board of Directors met on August 14, 2026, to consider and approve these results, along with the Limited Review Report. The company's operations are primarily in a single segment, making segmental reporting not applicable. The financial results have been prepared in accordance with Indian Accounting Standards (Ind AS). Previous period figures have been rearranged for comparability.

Ortin Global Ltd has announced that its Board of Directors will convene on August 14, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026, along with the limited review report. The meeting will also address any other business as permitted by the Chair. Additionally, the company has informed that the trading window for dealing in its securities remains closed from July 1, 2026, until 48 hours after the declaration of these financial results, in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015.

Rarever Financial Advisors Pvt Ltd, acting as the Manager to the Offer, has submitted a post-offer advertisement for Mr. Parveen Satija's open offer to acquire equity shares of Ortin Global Limited. The offer aimed to acquire 21,14,162 equity shares, representing 26% of the paid-up equity capital, at a price of ₹14.65 per share. The offer opened on June 5, 2026, and closed on June 18, 2026. The payment of consideration and communication of acceptance/rejection was completed by July 3, 2026. While the offer size was for 21,14,162 shares, only 226 shares were actually acquired in the open offer, representing a mere 0.003% of the target company's equity. Mr. Satija's pre-offer shareholding was NIL, and post-offer shareholding is 1.24% (1,00,526 shares).

Ortin Global Ltd has announced the closure of its trading window for all designated persons, their immediate relatives, and connected persons. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015 and the company's code of conduct. The trading window will be shut from July 1, 2026, until 48 hours after the declaration of the unaudited financial results for the quarter ending June 30, 2026. A board meeting will be convened to consider and approve these financial results, with a separate intimation to be sent to the stock exchange regarding the meeting notice.

Rarever Financial Advisors Private Limited, acting as the Manager to the Offer, has submitted a Pre-Offer Advertisement cum Corrigendum to the public announcement to the BSE. This filing pertains to an ongoing offer process, with further details expected in the detailed public announcement. Investors should refer to the official filings for comprehensive information regarding the offer.

Ortin Global Limited (formerly Ortin Laboratories Limited) announced audited financial results for the quarter and year ended March 31, 2026. The company reported a net loss before tax of ₹72.34 lakhs for the year ended March 31, 2026, compared to a loss of ₹83.75 lakhs in the previous year. Total income for the year stood at ₹4150 lakhs, compared to ₹3835 lakhs in the previous year. The Board of Directors approved the results in a meeting held on May 30, 2026.

Ortin Global Limited's board meeting on May 30, 2026, approved the audited financial results for the quarter and year ended March 31, 2026. The meeting, held at the company's registered office in Hyderabad, also included the approval of the Auditor’s Report along with the declaration as per Regulation 33 of SEBI (LODR) Regulations, 2015.

Ortin Global Ltd has scheduled a Board of Directors meeting on May 30, 2026, to consider and approve the audited standalone financial results along with the Auditor’s Report for the quarter and year ended March 31, 2026. The trading window is closed from April 1, 2026, until 48 hours after the declaration of the audited financial results.

Rarever Financial Advisors Pvt. Ltd., the manager to the open offer for Ortin Global Ltd, has announced that the identified date for determining the shareholders to whom the Letter of Offer will be sent is fixed as May 21, 2026. This is in compliance with Regulation 18(2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeover) Regulations, 2011.